MarketBeat on MSN
InflaRx investor update: Izicopan set to take center stage in AAV and renal disease pipeline
InflaRx (NASDAQ:IFRX) outlined plans to prioritize development of izicopan, an oral inhibitor of the C5a receptor (C5aR), in ...
The study provides the first detailed characterization of human antibodies targeting measles virus, offering a potential ...
Cells use a surprising “pearling” motion to evenly distribute mitochondrial DNA. This newly uncovered process may be key to ...
Researchers say identified mAbs could represent “a basis to develop a treatment that is urgently needed as measles virus ...
Since a landmark 2009 study, researchers have known that a common gut bacterium, Bacteroides fragilis, drives colon tumor ...
The treatment consists of a Bluetooth headset that patients can connect to an app on their smartphones. It could mark a ...
At a wastewater plant in northern Spain, researchers are testing a ceramic membrane technology that converts biogas into low-carbon hydrogen – offering a glimpse of how Europe could decarbonise ...
Guarantee as a Policy Fact: The MemoPryl manufacturer provides a 60-day money-back guarantee. As a matter of policy, ...
A protein found only in microscopic tardigrades, one that allows them to survive extreme conditions like dehydration, can convey similar durability in synthetic cells, according to new research from ...
For decades, antimicrobial peptides (AMPs) and amyloid-forming peptides were studied in largely separate contexts. AMPs were ...
The pH meters are electronic devices designed to measure the acidity or alkalinity by detecting the voltage produced by a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results